China NMPA Product Recall - Free thyroxine assay kit

The National Medical Products Administration (NMPA) announced a voluntary Class III recall initiated by Abbott Trading (Shanghai) Co., Ltd. This recall specifically targets the company's Free Thyroxine Assay Kits, identified under Registration No.: 2016240. The critical issue prompting this action was the discovery that the affected products did not consistently meet the required precision and linearity standards for the assay. Such deficiencies can significantly impact the reliability of diagnostic test results, posing potential risks in patient management, particularly concerning thyroid function assessments. Abbott Trading (Shanghai) Co., Ltd. is undertaking a comprehensive recall of these kits to mitigate any potential adverse effects on patient care. The 'Medical Device Recall Event Report Form' provides a detailed account of the affected product models, specifications, and batch numbers, ensuring transparent identification of all impacted units. This recall underscores the rigorous regulatory framework enforced by the NMPA to safeguard public health and ensure the quality and performance of medical devices circulating in the market. The Class III classification indicates that while there's a low probability of serious adverse health consequences, the product deviates from acceptable performance standards, necessitating its removal from use.